Shares of Berkshire Hathaway Inc. Cl B inched 0.65% higher to $365.52 Monday, on what proved to be an all-around favorable trading session for the stock...
Shares of Berkshire Hathaway Inc. Cl B BRK.B, +0.65% inched 0.65% higher to $365.52 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX, +0.67% rising 0.67% to 4,487.46 and the Dow Jones Industrial Average DJIA, +0.25% rising 0.25% to 34,663.72.Berkshire Hathaway Inc. Cl B closed $0.95 short of its 52-week high , which the company achieved on September 5th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Honeywell International Inc. HON, +0.92% rose 0.92% to $186.21, General Electric Co. GE, +2.27% rose 2.27% to $114.26, and Illinois Tool Works Inc. ITW, -0.17% fell 0.17% to $238.04. Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
4 Huge Analyst Calls: Block Slashed on 'Lack of Catalysts'; Chewy Bumped to BuyStocks Analysis by Investing.com (Garrett Cook) covering: Block Inc, Chewy Inc, Cloudflare Inc, Surf Air Mobility Inc. Read Investing.com (Garrett Cook)'s latest article on Investing.com
Read more »
GE HealthCare Technologies Inc Stock Price Today | NASDAQ GEHC Live TickerView today's GE HealthCare Technologies Inc stock price and latest GEHC news and analysis. Create real-time notifications to follow any changes in the live stock price.
Read more »
5 things to know before the stock market opens MondayHere are the most important news items that investors need to start their trading day.
Read more »
Jim Cramer's top 10 things to watch in the stock market MondayStocks are on track to open the week higher, as investors look ahead to a raft of U.S. economic data.
Read more »
Pfizer and Moderna updated COVID vaccines approved by FDAThe U.S. Food and Drug Administration on Monday approved updated mRNA COVID vaccines from Moderna Inc. and Pfizer Inc. People five years of age and older are...
Read more »